Replies to Post #200353 onBiotech Values | InvestorsHub

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Replies to post #200353 on Biotech Values

Replies to #200353 on Biotech Values

04/20/16 5:23 PM

#200876 RE: DewDiligence #200353

EIGR licenses BMY’s IFN Lambda for undisclosed (presumably small) price:

http://finance.yahoo.com/news/eiger-biopharmaceuticals-announces-license-worldwide-203000440.html

EIGR is the result of a recent reverse merger with CLDN (#msg-121359837).

01/16/18 9:38 AM

#216615 RE: DewDiligence #200353

EIGR—(-44%)—fails phase-2 in PAH—program terminated:

https://finance.yahoo.com/news/eiger-biopharmaceuticals-announces-phase-2-130000999.html